Tirzepatide Safety in Type 2 Diabetes: A Disproportionality Analysis of Adverse Events Using the FDA FAERS Database.
Tirzepatide 在第二型糖尿病中的安全性:利用美國 FDA FAERS 資料庫進行不同比例不良事件分析
Endocr Connect 2025-07-09
Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning.
GLP-1 Receptor Agonist 副作用之探討:以確保其最佳定位
Diabetes Metab J 2025-07-09
Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study.
Semaglutide 治療與年長第二型糖尿病患者加速性肌少症:24 個月回溯性世代研究
Drug Des Devel Ther 2025-07-09
Long-acting hydrogel-based depot formulations of tirzepatide and semaglutide for the management of type 2 diabetes and weight.
Tirzepatide 與 semaglutide 長效水凝膠型緩釋劑型於第二型糖尿病與體重管理之應用
bioRxiv 2025-07-09
Dose-Dependent Efficacy and Safety of Tirzepatide for Weight Loss in Non-diabetic Adults With Obesity: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Tirzepatide 對非糖尿病肥胖成人體重減輕的劑量依賴性療效與安全性:隨機對照試驗的系統性回顧與統合分析
Cureus 2025-07-09
The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity.
Retatrutide 對第二型糖尿病及/或肥胖參與者腎臟指標的影響
Kidney Int Rep 2025-07-09
Research on the effects of GLP-1 receptor agonists in treating cognitive dysfunction and gait disorders in elderly patients with diabetes.
GLP-1 受體促效劑治療老年糖尿病患者認知功能障礙與步態障礙之效果研究
Front Pharmacol 2025-07-09